STVN (STVN) Stock Price & Analysis
STVN (STVN) rose 0.56% to USD 18.1 as of June 10, 2026 at 00:47 UTC, according to Nexqual real-time market data.
STVN last closed at USD 18; the session ranged USD 17.83–18.8 on volume of 449,032 shares. Market capitalization is $4.94B, with a 52-week range of USD 12.89–28 (NYQ). Source: Nexqual, June 10, 2026 at 00:47 UTC.
Key Statistics (as of June 10, 2026 at 00:47 UTC)
| Price | USD 18.1 |
|---|---|
| Change | ▲ 0.56% (up) |
| Previous Close | USD 18 |
| Open | USD 18.25 |
| Day Range | USD 17.83 – 18.8 |
| 52-Week Range | USD 12.89 – 28 |
| Volume | 449,032 shares |
| Market Cap | $4.94B |
| Exchange | NYQ |
Technical Analysis (STVN)
Nexqual's technical model rates STVN "BUY" based on 4 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 00:47 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 57.76 (neutral) |
| vs SMA50 | Above (USD 16.65) |
| MACD | 0.39 (positive) |
Analyst Ratings (STVN)
Wall Street analysts rate STVN "Buy" based on 9 analysts, with a mean price target of USD 24.39 (range USD 17.5–32), per Nexqual as of June 10, 2026 at 00:47 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 9 |
| Mean Target | USD 24.39 |
| High Target | USD 32 |
| Low Target | USD 17.5 |
| Buy / Hold / Sell | 8 / 2 / 0 |
Earnings (STVN)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD 0.15 |
| Revenue Estimate | $298.57M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.13 vs est 0.12 ▲ beat |
| 2025-12-31 | USD 0.21 vs est 0.2 ▲ beat |
| 2025-09-30 | USD 0.16 vs est 0.15 ▲ beat |
| 2025-06-30 | USD 0.13 vs est 0.12 ▲ beat |
Source: Nexqual, June 10, 2026 at 00:47 UTC.
Financials & Fundamentals (STVN)
| Total Revenue | $1.20B |
|---|---|
| Revenue Growth (YoY) | +6.60% |
| Gross Margin | +29.22% |
| Operating Margin | +14.24% |
| Profit Margin | +11.75% |
| ROE | +9.59% |
| Debt / Equity | 29.43 |
| Current Ratio | 1.63 |
| Total Cash | $112.28M |
| Total Debt | $450.58M |
| Free Cash Flow | $-57.06M |
Source: Nexqual, June 10, 2026 at 00:47 UTC.
Financial Health Score (STVN)
Nexqual rates STVN's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:47 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 29%, operating 14% |
| Balance Sheet | Strong — $112M cash vs $451M debt |
| Cash Flow | Weak — FCF negative: -$57M, burning cash |
| Efficiency | Mixed — ROE 10%, ROA 5.3% |
Ownership (STVN)
| Insider Ownership | +1.58% |
|---|---|
| Institutional Ownership | +96.52% |
| Shares Outstanding | 49.71M |
| Float | 48.95M |
| Short % of Float | +2.06% |
Source: Nexqual, June 10, 2026 at 00:47 UTC.
Leadership (STVN)
STVN is led by Franco Stevanato (age 52), CEO & Executive Chairman, per Nexqual as of June 10, 2026 at 00:47 UTC.
| CEO & Executive Chairman | Franco Stevanato (age 52) |
|---|---|
| Chief Financial Officer | Marco Dal Lago (age 52) |
| President of DDS & IVD Business Unit | Michele Monico |
| President of Engineering Business Unit | Raffaele Pace |
Major Backers & Investors (STVN)
Notable institutional backers of STVN include Conestoga Capital Advisors, LLC, Neuberger Berman Group, LLC, T. Rowe Price, according to Nexqual as of June 10, 2026 at 00:47 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Conestoga Capital Advisors, LLC | 2.8% |
| Neuberger Berman Group, LLC | 2.33% |
| T. Rowe Price | 1.73% |
| Conestoga Funds-Conestoga Small Cap Fund | 1.45% |
| Times Square Capital Management, LLC | 1.15% |
| Artisan Partners Limited Partnership | 1.04% |
| BAMCO Inc. | 0.83% |
| BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd. | 0.56% |
Source: Nexqual, June 10, 2026 at 00:47 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PRVA | Privia Health Group, Inc. | USD 22.17 | ▲ 2.5% |
| SHC | Sotera Health Company | USD 16.53 | ▲ 5.83% |
| HAYW | Hayward Holdings, Inc. | USD 14.7 | ▲ 4.48% |
| BLCO | Bausch + Lomb Corporation | USD 15.65 | ▲ 1.23% |
| LFST | LifeStance Health Group, Inc. | USD 7.66 | ▲ 3.37% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:47 UTC. This page is informational and not investment advice.